Baidu
map

Acta Neurol Scand:亨廷顿氏舞蹈病患者卒中发生的流行病学调查

2015-09-29 phylis 译 MedSci原创

目的:糖尿病和高胆固醇血症是卒中发生的危险因素,并且有报道称患有亨廷顿氏舞蹈病(HD)的患者存在糖和胆固醇代谢的改变。研究人员调查了这类人群卒中的发生率及危险因素。方法:在国家登记册中筛选出HD患者192名。从患者记录中获得卒中发生,无症状性脑梗以及危险因素的数据。结果:五个患者发生缺血性脑卒中,表明发病率为42/100000人每年。13名患者发生无症状性脑梗,2名患者发生出血性卒中,没有发现发生

目的:糖尿病和高胆固醇血症是卒中发生的危险因素,并且有报道称患有亨廷顿氏舞蹈病(HD)的患者存在糖和胆固醇代谢的改变。研究人员调查了这类人群卒中的发生率及危险因素。

方法:在国家登记册中筛选出HD患者192名。从患者记录中获得卒中发生,无症状性脑梗以及危险因素的数据。

结果:五个患者发生缺血性脑卒中,表明发病率为42/100000人每年。13名患者发生无症状性脑梗,2名患者发生出血性卒中,没有发现发生短暂性脑缺血发作(TIA)的患者。到65岁,缺血性卒中的累积发病率为2.7%,无症状性脑梗的累积发生率为6.7%。用CAP分数评估基因因素的影响,IS或无症状性脑梗的CAP分数为495 ± 117,无缺血性事件发生的CAP分数为568 ± 126。IS或无症状性梗死的患者危险因素诊断的频率至少是非卒中患者的2倍。

结论:HD患者和一般人群脑血管疾病的发生同样常见,但是轻微脑血管事件和血管事件的危险因素尚未识别。HTT基因突变似乎并未增加卒中发生的风险。

原文出处:

Sipilä JO, Majamaa K.  Epidemiology of stroke in Finnish patients with Huntington's disease. Acta Neurol Scand. 2015 Sep 25.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999574, encodeId=488419995e4e2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 02 17:29:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849515, encodeId=afd6184951563, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed May 18 21:29:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411233, encodeId=197014112335c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423782, encodeId=795d1423e827d, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622738, encodeId=3a321622e380b, content=<a href='/topic/show?id=4a6e2454879' target=_blank style='color:#2F92EE;'>#亨廷顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24548, encryptionId=4a6e2454879, topicName=亨廷顿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
    2016-04-02 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999574, encodeId=488419995e4e2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 02 17:29:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849515, encodeId=afd6184951563, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed May 18 21:29:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411233, encodeId=197014112335c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423782, encodeId=795d1423e827d, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622738, encodeId=3a321622e380b, content=<a href='/topic/show?id=4a6e2454879' target=_blank style='color:#2F92EE;'>#亨廷顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24548, encryptionId=4a6e2454879, topicName=亨廷顿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
    2016-05-18 windight
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999574, encodeId=488419995e4e2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 02 17:29:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849515, encodeId=afd6184951563, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed May 18 21:29:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411233, encodeId=197014112335c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423782, encodeId=795d1423e827d, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622738, encodeId=3a321622e380b, content=<a href='/topic/show?id=4a6e2454879' target=_blank style='color:#2F92EE;'>#亨廷顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24548, encryptionId=4a6e2454879, topicName=亨廷顿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
    2015-10-01 xugumin
  4. [GetPortalCommentsPageByObjectIdResponse(id=1999574, encodeId=488419995e4e2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 02 17:29:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849515, encodeId=afd6184951563, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed May 18 21:29:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411233, encodeId=197014112335c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423782, encodeId=795d1423e827d, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622738, encodeId=3a321622e380b, content=<a href='/topic/show?id=4a6e2454879' target=_blank style='color:#2F92EE;'>#亨廷顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24548, encryptionId=4a6e2454879, topicName=亨廷顿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1999574, encodeId=488419995e4e2, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sat Apr 02 17:29:00 CST 2016, time=2016-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1849515, encodeId=afd6184951563, content=<a href='/topic/show?id=61815385aa' target=_blank style='color:#2F92EE;'>#CTA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5385, encryptionId=61815385aa, topicName=CTA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Wed May 18 21:29:00 CST 2016, time=2016-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411233, encodeId=197014112335c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1423782, encodeId=795d1423e827d, content=<a href='/topic/show?id=abfd6539566' target=_blank style='color:#2F92EE;'>#流行病学调查#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65395, encryptionId=abfd6539566, topicName=流行病学调查)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bc93846316, createdName=charl1234568, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622738, encodeId=3a321622e380b, content=<a href='/topic/show?id=4a6e2454879' target=_blank style='color:#2F92EE;'>#亨廷顿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24548, encryptionId=4a6e2454879, topicName=亨廷顿)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 01 06:29:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]

相关资讯

J Neurol:血糖控制对脑缺血患者静脉溶栓治疗预后的影响

脑缺血发生后溶栓治疗的一小时内是否血糖控制,是否影响预后尚不清楚。我们主要想评估血糖控制水平以及急性脑缺血溶栓后血糖控制良好的患者是否有较好的预后。在里尔大学医院,我们回顾性分析了预先收集的一些进行静脉溶栓的卒中病人。卒中后的前48h内,任意时刻的血糖高于1.6 g/l (8.9 mmol/l)患者给予胰岛素治疗。血糖控制良好的两个定义:ⅰ良好控制100%,即血糖100%低于1.6&nb

Lancet:警惕短暂性脑缺血发作所引发的卒中

由血栓短暂性阻断脑血流所致的短暂性脑缺血发作(TIA),在英国每年的初发患者达46000人。因其结局最终会发生戏剧性的好转,患者经常会忽略其症状,认为其是由于其他疾病或老龄所致。然而,10%的TIA患者在发病后的7天内会继续进展而发生卒中。 尽管英国全国性的运动已增加了对与卒中症状的意识,但公众对于TIA症状以及立即就诊的重要性的意识仍然很弱。在一项由卒中协会(英国一个慈善机构)进行的调查中

Neurology:脑缺血患者溶栓前中性粒细胞高,患者预后差

目的:为了确定缺血性卒中(IS)患者,静脉给予rtPA溶栓前,较高的中性粒细胞计数与症状性脑出血(sICH)和3月不良预后之间的关系。方法:在里尔和赫尔辛基群体研究中,给予IS患者rtPA治疗前,检测血液中白细胞,中性粒细胞以及淋巴细胞计数。主要终点为sICH(欧洲急性脑卒中Ⅱ定义)。次要终点为死亡以及3个月极好预后(mRS分数0-1或等于卒中前),良好预后(mRS分数为0-2或等于卒中前)。结果

Stroke:可溶性CD40L是预测未来卒中的有效标志物

可溶性CD40配体(sCD40L)的升高已被证实与心血管事件相关,然而目前关于sCD40L在预测卒中复发方面的作用还尚不明确。研究方法:我们对3044位患有急性轻微卒中和短暂性脑缺血发作的连续患者的基线sCD40L水平进行了检测。这些患者之前已经加入针对急性无症状脑血管事件(CHANCE)高风险患者应用氯吡格雷的研究。我们利用cox比例风险模型评估sCD40L与卒中复发之间的关联。研究结果:经过对

NRR:人参皂苷Rb1防治脑缺血后神经元损伤的临床价值

脑缺血缺氧时,活化态小胶质细胞介导的炎症反应促进了神经元损伤。因此,寻找能抑制活化的小胶质细胞介导的神经元损伤的药物,是当前防治缺血缺氧性脑病研究领域亟待解决的热点问题之一。 由柯荔宁博士所在的中国南方医科大学和福建医科大学研究人员构成的联合研究团队,应用小胶质细胞与神经元共培养,并加入中国传统中药人参皂苷作为药物干预手段。可靠的结果证明人参皂苷Rb1可能通过下调缺氧活化的小胶质细胞中的一氧化氮

Stroke:可疑迟发型脑缺血诊断策略的效能

迟发型脑缺血是蛛网膜下腔出血后一类严重的并发症。如果临床怀疑DCI,在建立治疗之前,影像学方法主要起监测作用,通过血管造影判断血管痉挛和局部低灌注是常用手段。以影像学成像血管痉挛或灌注缺损与DCI相关结局之间的联系强度进而提出一个问题——以治疗为目的,利用影像学方法去筛选病人能否提高临床DCI患者的预后。 研究方法: 应用马尔科夫模型来进行决策分析。策略是迅速治疗所有患者或首先

Baidu
map
Baidu
map
Baidu
map